世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
プレフィルドシリンジの世界市場成長率2024-2030年Global Prefilled Syringes Drug Molecules Market Growth 2024-2030 世界のプレフィルドシリンジ薬剤分子市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測されており、2024年から2030年にかけて年平均成長率%で成長すると予測されています。 LPインフォ... もっと見る
日本語のページは自動翻訳を利用し作成しています。 
サマリー世界のプレフィルドシリンジ薬剤分子市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測されており、2024年から2030年にかけて年平均成長率%で成長すると予測されています。LPインフォメーション社の最新調査レポート「プレフィルドシリンジ薬剤分子産業予測」は、2023年のプレフィルドシリンジ薬剤分子の世界総売上高を過去の売上高と比較し、2024年から2030年までのプレフィルドシリンジ薬剤分子の売上高予測について地域別・市場分野別に包括的に分析しています。プレフィルドシリンジ医薬分子売上高を地域別、市場分野別、サブセクター別に分類し、世界のプレフィルドシリンジ医薬分子産業の詳細な分析を百万米ドル単位で提供します。 この調査レポートは、世界のプレフィルドシリンジ 医薬品分子業界を包括的に分析し、製品セグメンテーション、企業形成、収益、市場シェア、最新動向、M&A活動などに関する主要動向を明らかにしています。また、本レポートでは、加速する世界のプレフィルドシリンジ薬剤分子市場におけるこれらの企業の独自のポジションをより良く理解するために、プレフィルドシリンジ薬剤分子のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析しています。 この調査レポートは、プレフィルドシリンジ薬剤分子の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界のプレフィルドシリンジ医薬分子の現状と将来の軌道について非常にニュアンスのある見解を提供します。 世界の医薬品市場は2022年に1475億米ドルとなり、今後6年間のCAGRは5％で成長する。医薬品市場には化学医薬品と生物学的医薬品が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間＆政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調しています。 当レポートでは、プレフィルドシリンジ医薬分子市場の製品タイプ別、用途別、主要メーカー別、主要地域別および国別の包括的な概要、市場シェア、成長機会を紹介しています。 タイプ別セグメント ワクチン インスリン アドレナリン オピオイド その他 用途別セグメント 小売薬局 病院薬局 オンライン薬局 本レポートではまた、市場を地域別に分けています： 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 メルク アストラゼネカ ジョンソン・エンド・ジョンソン サノフィ マイラン アムジェン ノバルティス テバ・ファーマシューティカル・インダストリーズ ファイザー GSK フレゼニウス・カビ 本レポートで扱う主な質問 世界のプレフィルドシリンジ分子標的薬市場の10年展望は？ プレフィルドシリンジ医薬分子市場の成長を促進する世界および地域別の要因は何か？ 市場別、地域別で最も急成長する技術は何か？ プレフィルドシリンジ医薬分子市場の機会は最終市場規模によってどのように異なるのか？ プレフィルドシリンジ医薬分子はどのようにタイプ、用途に分かれるのか？ 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Prefilled Syringes Drug Molecules Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Prefilled Syringes Drug Molecules by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Prefilled Syringes Drug Molecules by Country/Region, 2019, 2023 & 2030 2.2 Prefilled Syringes Drug Molecules Segment by Type 2.2.1 Vaccines 2.2.2 Insulin 2.2.3 Adrenaline 2.2.4 Opioids 2.2.5 Others 2.3 Prefilled Syringes Drug Molecules Sales by Type 2.3.1 Global Prefilled Syringes Drug Molecules Sales Market Share by Type (2019-2024) 2.3.2 Global Prefilled Syringes Drug Molecules Revenue and Market Share by Type (2019-2024) 2.3.3 Global Prefilled Syringes Drug Molecules Sale Price by Type (2019-2024) 2.4 Prefilled Syringes Drug Molecules Segment by Application 2.4.1 Retail Pharmacies 2.4.2 Hospital Pharmacies 2.4.3 Online Pharmacies 2.5 Prefilled Syringes Drug Molecules Sales by Application 2.5.1 Global Prefilled Syringes Drug Molecules Sale Market Share by Application (2019-2024) 2.5.2 Global Prefilled Syringes Drug Molecules Revenue and Market Share by Application (2019-2024) 2.5.3 Global Prefilled Syringes Drug Molecules Sale Price by Application (2019-2024) 3 Global Prefilled Syringes Drug Molecules by Company 3.1 Global Prefilled Syringes Drug Molecules Breakdown Data by Company 3.1.1 Global Prefilled Syringes Drug Molecules Annual Sales by Company (2019-2024) 3.1.2 Global Prefilled Syringes Drug Molecules Sales Market Share by Company (2019-2024) 3.2 Global Prefilled Syringes Drug Molecules Annual Revenue by Company (2019-2024) 3.2.1 Global Prefilled Syringes Drug Molecules Revenue by Company (2019-2024) 3.2.2 Global Prefilled Syringes Drug Molecules Revenue Market Share by Company (2019-2024) 3.3 Global Prefilled Syringes Drug Molecules Sale Price by Company 3.4 Key Manufacturers Prefilled Syringes Drug Molecules Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Prefilled Syringes Drug Molecules Product Location Distribution 3.4.2 Players Prefilled Syringes Drug Molecules Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Prefilled Syringes Drug Molecules by Geographic Region 4.1 World Historic Prefilled Syringes Drug Molecules Market Size by Geographic Region (2019-2024) 4.1.1 Global Prefilled Syringes Drug Molecules Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Prefilled Syringes Drug Molecules Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Prefilled Syringes Drug Molecules Market Size by Country/Region (2019-2024) 4.2.1 Global Prefilled Syringes Drug Molecules Annual Sales by Country/Region (2019-2024) 4.2.2 Global Prefilled Syringes Drug Molecules Annual Revenue by Country/Region (2019-2024) 4.3 Americas Prefilled Syringes Drug Molecules Sales Growth 4.4 APAC Prefilled Syringes Drug Molecules Sales Growth 4.5 Europe Prefilled Syringes Drug Molecules Sales Growth 4.6 Middle East & Africa Prefilled Syringes Drug Molecules Sales Growth 5 Americas 5.1 Americas Prefilled Syringes Drug Molecules Sales by Country 5.1.1 Americas Prefilled Syringes Drug Molecules Sales by Country (2019-2024) 5.1.2 Americas Prefilled Syringes Drug Molecules Revenue by Country (2019-2024) 5.2 Americas Prefilled Syringes Drug Molecules Sales by Type 5.3 Americas Prefilled Syringes Drug Molecules Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Prefilled Syringes Drug Molecules Sales by Region 6.1.1 APAC Prefilled Syringes Drug Molecules Sales by Region (2019-2024) 6.1.2 APAC Prefilled Syringes Drug Molecules Revenue by Region (2019-2024) 6.2 APAC Prefilled Syringes Drug Molecules Sales by Type 6.3 APAC Prefilled Syringes Drug Molecules Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Prefilled Syringes Drug Molecules by Country 7.1.1 Europe Prefilled Syringes Drug Molecules Sales by Country (2019-2024) 7.1.2 Europe Prefilled Syringes Drug Molecules Revenue by Country (2019-2024) 7.2 Europe Prefilled Syringes Drug Molecules Sales by Type 7.3 Europe Prefilled Syringes Drug Molecules Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Prefilled Syringes Drug Molecules by Country 8.1.1 Middle East & Africa Prefilled Syringes Drug Molecules Sales by Country (2019-2024) 8.1.2 Middle East & Africa Prefilled Syringes Drug Molecules Revenue by Country (2019-2024) 8.2 Middle East & Africa Prefilled Syringes Drug Molecules Sales by Type 8.3 Middle East & Africa Prefilled Syringes Drug Molecules Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Prefilled Syringes Drug Molecules 10.3 Manufacturing Process Analysis of Prefilled Syringes Drug Molecules 10.4 Industry Chain Structure of Prefilled Syringes Drug Molecules 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Prefilled Syringes Drug Molecules Distributors 11.3 Prefilled Syringes Drug Molecules Customer 12 World Forecast Review for Prefilled Syringes Drug Molecules by Geographic Region 12.1 Global Prefilled Syringes Drug Molecules Market Size Forecast by Region 12.1.1 Global Prefilled Syringes Drug Molecules Forecast by Region (2025-2030) 12.1.2 Global Prefilled Syringes Drug Molecules Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Prefilled Syringes Drug Molecules Forecast by Type 12.7 Global Prefilled Syringes Drug Molecules Forecast by Application 13 Key Players Analysis 13.1 Merck 13.1.1 Merck Company Information 13.1.2 Merck Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.1.3 Merck Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Merck Main Business Overview 13.1.5 Merck Latest Developments 13.2 AstraZeneca 13.2.1 AstraZeneca Company Information 13.2.2 AstraZeneca Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.2.3 AstraZeneca Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 AstraZeneca Main Business Overview 13.2.5 AstraZeneca Latest Developments 13.3 Johnson & Johnson 13.3.1 Johnson & Johnson Company Information 13.3.2 Johnson & Johnson Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.3.3 Johnson & Johnson Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Johnson & Johnson Main Business Overview 13.3.5 Johnson & Johnson Latest Developments 13.4 SANOFI 13.4.1 SANOFI Company Information 13.4.2 SANOFI Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.4.3 SANOFI Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 SANOFI Main Business Overview 13.4.5 SANOFI Latest Developments 13.5 Mylan 13.5.1 Mylan Company Information 13.5.2 Mylan Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.5.3 Mylan Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Mylan Main Business Overview 13.5.5 Mylan Latest Developments 13.6 Amgen 13.6.1 Amgen Company Information 13.6.2 Amgen Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.6.3 Amgen Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Amgen Main Business Overview 13.6.5 Amgen Latest Developments 13.7 Novartis 13.7.1 Novartis Company Information 13.7.2 Novartis Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.7.3 Novartis Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Novartis Main Business Overview 13.7.5 Novartis Latest Developments 13.8 Teva Pharmaceutical Industries 13.8.1 Teva Pharmaceutical Industries Company Information 13.8.2 Teva Pharmaceutical Industries Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.8.3 Teva Pharmaceutical Industries Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Teva Pharmaceutical Industries Main Business Overview 13.8.5 Teva Pharmaceutical Industries Latest Developments 13.9 Pfizer 13.9.1 Pfizer Company Information 13.9.2 Pfizer Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.9.3 Pfizer Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Pfizer Main Business Overview 13.9.5 Pfizer Latest Developments 13.10 GSK 13.10.1 GSK Company Information 13.10.2 GSK Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.10.3 GSK Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 GSK Main Business Overview 13.10.5 GSK Latest Developments 13.11 Fresenius Kabi 13.11.1 Fresenius Kabi Company Information 13.11.2 Fresenius Kabi Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.11.3 Fresenius Kabi Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Fresenius Kabi Main Business Overview 13.11.5 Fresenius Kabi Latest Developments 14 Research Findings and Conclusion
SummaryThe global Prefilled Syringes Drug Molecules market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Prefilled Syringes Drug Molecules Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Prefilled Syringes Drug Molecules by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Prefilled Syringes Drug Molecules by Country/Region, 2019, 2023 & 2030 2.2 Prefilled Syringes Drug Molecules Segment by Type 2.2.1 Vaccines 2.2.2 Insulin 2.2.3 Adrenaline 2.2.4 Opioids 2.2.5 Others 2.3 Prefilled Syringes Drug Molecules Sales by Type 2.3.1 Global Prefilled Syringes Drug Molecules Sales Market Share by Type (2019-2024) 2.3.2 Global Prefilled Syringes Drug Molecules Revenue and Market Share by Type (2019-2024) 2.3.3 Global Prefilled Syringes Drug Molecules Sale Price by Type (2019-2024) 2.4 Prefilled Syringes Drug Molecules Segment by Application 2.4.1 Retail Pharmacies 2.4.2 Hospital Pharmacies 2.4.3 Online Pharmacies 2.5 Prefilled Syringes Drug Molecules Sales by Application 2.5.1 Global Prefilled Syringes Drug Molecules Sale Market Share by Application (2019-2024) 2.5.2 Global Prefilled Syringes Drug Molecules Revenue and Market Share by Application (2019-2024) 2.5.3 Global Prefilled Syringes Drug Molecules Sale Price by Application (2019-2024) 3 Global Prefilled Syringes Drug Molecules by Company 3.1 Global Prefilled Syringes Drug Molecules Breakdown Data by Company 3.1.1 Global Prefilled Syringes Drug Molecules Annual Sales by Company (2019-2024) 3.1.2 Global Prefilled Syringes Drug Molecules Sales Market Share by Company (2019-2024) 3.2 Global Prefilled Syringes Drug Molecules Annual Revenue by Company (2019-2024) 3.2.1 Global Prefilled Syringes Drug Molecules Revenue by Company (2019-2024) 3.2.2 Global Prefilled Syringes Drug Molecules Revenue Market Share by Company (2019-2024) 3.3 Global Prefilled Syringes Drug Molecules Sale Price by Company 3.4 Key Manufacturers Prefilled Syringes Drug Molecules Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Prefilled Syringes Drug Molecules Product Location Distribution 3.4.2 Players Prefilled Syringes Drug Molecules Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Prefilled Syringes Drug Molecules by Geographic Region 4.1 World Historic Prefilled Syringes Drug Molecules Market Size by Geographic Region (2019-2024) 4.1.1 Global Prefilled Syringes Drug Molecules Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Prefilled Syringes Drug Molecules Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Prefilled Syringes Drug Molecules Market Size by Country/Region (2019-2024) 4.2.1 Global Prefilled Syringes Drug Molecules Annual Sales by Country/Region (2019-2024) 4.2.2 Global Prefilled Syringes Drug Molecules Annual Revenue by Country/Region (2019-2024) 4.3 Americas Prefilled Syringes Drug Molecules Sales Growth 4.4 APAC Prefilled Syringes Drug Molecules Sales Growth 4.5 Europe Prefilled Syringes Drug Molecules Sales Growth 4.6 Middle East & Africa Prefilled Syringes Drug Molecules Sales Growth 5 Americas 5.1 Americas Prefilled Syringes Drug Molecules Sales by Country 5.1.1 Americas Prefilled Syringes Drug Molecules Sales by Country (2019-2024) 5.1.2 Americas Prefilled Syringes Drug Molecules Revenue by Country (2019-2024) 5.2 Americas Prefilled Syringes Drug Molecules Sales by Type 5.3 Americas Prefilled Syringes Drug Molecules Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Prefilled Syringes Drug Molecules Sales by Region 6.1.1 APAC Prefilled Syringes Drug Molecules Sales by Region (2019-2024) 6.1.2 APAC Prefilled Syringes Drug Molecules Revenue by Region (2019-2024) 6.2 APAC Prefilled Syringes Drug Molecules Sales by Type 6.3 APAC Prefilled Syringes Drug Molecules Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Prefilled Syringes Drug Molecules by Country 7.1.1 Europe Prefilled Syringes Drug Molecules Sales by Country (2019-2024) 7.1.2 Europe Prefilled Syringes Drug Molecules Revenue by Country (2019-2024) 7.2 Europe Prefilled Syringes Drug Molecules Sales by Type 7.3 Europe Prefilled Syringes Drug Molecules Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Prefilled Syringes Drug Molecules by Country 8.1.1 Middle East & Africa Prefilled Syringes Drug Molecules Sales by Country (2019-2024) 8.1.2 Middle East & Africa Prefilled Syringes Drug Molecules Revenue by Country (2019-2024) 8.2 Middle East & Africa Prefilled Syringes Drug Molecules Sales by Type 8.3 Middle East & Africa Prefilled Syringes Drug Molecules Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Prefilled Syringes Drug Molecules 10.3 Manufacturing Process Analysis of Prefilled Syringes Drug Molecules 10.4 Industry Chain Structure of Prefilled Syringes Drug Molecules 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Prefilled Syringes Drug Molecules Distributors 11.3 Prefilled Syringes Drug Molecules Customer 12 World Forecast Review for Prefilled Syringes Drug Molecules by Geographic Region 12.1 Global Prefilled Syringes Drug Molecules Market Size Forecast by Region 12.1.1 Global Prefilled Syringes Drug Molecules Forecast by Region (2025-2030) 12.1.2 Global Prefilled Syringes Drug Molecules Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Prefilled Syringes Drug Molecules Forecast by Type 12.7 Global Prefilled Syringes Drug Molecules Forecast by Application 13 Key Players Analysis 13.1 Merck 13.1.1 Merck Company Information 13.1.2 Merck Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.1.3 Merck Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Merck Main Business Overview 13.1.5 Merck Latest Developments 13.2 AstraZeneca 13.2.1 AstraZeneca Company Information 13.2.2 AstraZeneca Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.2.3 AstraZeneca Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 AstraZeneca Main Business Overview 13.2.5 AstraZeneca Latest Developments 13.3 Johnson & Johnson 13.3.1 Johnson & Johnson Company Information 13.3.2 Johnson & Johnson Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.3.3 Johnson & Johnson Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Johnson & Johnson Main Business Overview 13.3.5 Johnson & Johnson Latest Developments 13.4 SANOFI 13.4.1 SANOFI Company Information 13.4.2 SANOFI Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.4.3 SANOFI Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 SANOFI Main Business Overview 13.4.5 SANOFI Latest Developments 13.5 Mylan 13.5.1 Mylan Company Information 13.5.2 Mylan Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.5.3 Mylan Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Mylan Main Business Overview 13.5.5 Mylan Latest Developments 13.6 Amgen 13.6.1 Amgen Company Information 13.6.2 Amgen Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.6.3 Amgen Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Amgen Main Business Overview 13.6.5 Amgen Latest Developments 13.7 Novartis 13.7.1 Novartis Company Information 13.7.2 Novartis Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.7.3 Novartis Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Novartis Main Business Overview 13.7.5 Novartis Latest Developments 13.8 Teva Pharmaceutical Industries 13.8.1 Teva Pharmaceutical Industries Company Information 13.8.2 Teva Pharmaceutical Industries Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.8.3 Teva Pharmaceutical Industries Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Teva Pharmaceutical Industries Main Business Overview 13.8.5 Teva Pharmaceutical Industries Latest Developments 13.9 Pfizer 13.9.1 Pfizer Company Information 13.9.2 Pfizer Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.9.3 Pfizer Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Pfizer Main Business Overview 13.9.5 Pfizer Latest Developments 13.10 GSK 13.10.1 GSK Company Information 13.10.2 GSK Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.10.3 GSK Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 GSK Main Business Overview 13.10.5 GSK Latest Developments 13.11 Fresenius Kabi 13.11.1 Fresenius Kabi Company Information 13.11.2 Fresenius Kabi Prefilled Syringes Drug Molecules Product Portfolios and Specifications 13.11.3 Fresenius Kabi Prefilled Syringes Drug Molecules Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Fresenius Kabi Main Business Overview 13.11.5 Fresenius Kabi Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
LP Information社の医薬品・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（syringes）の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |
